GRCE - Grace Therapeutics Inc Sotuvning sof marjinal rentabelligi

Grace Tx - GRCE emitenti grafik logotipi

GURU.Markets platformasida sof foyda marjasi tarixini baholagach, biz 0.00 belgisi ushbu metrikani qayd etishini aniqladik. Grace Therapeutics, Inc. (GRCE) nevrologik buzilishlar uchun noyob terapiyalarni yaratadi va muqobillarning yo'qligi tufayli narxlarni belgilash imkoniyatiga ega bo'ladi. Kamyob komponentlar ta'minot zanjirlarining optimallashtirilishi yuqori daromadli faoliyatni qo'llab-quvvatlaydi. FDA eksklyuzivligi va himoyalangan yetkazib berish formulalari arzon generiklar yaratuvchilariga bozorga kirishni to'sadi.

gracetx.com (GRCE) Sof foyda marjasi: 29.10.2024 - 20.11.2026 davri uchun

GRCE (Grace Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi statistikasi:
Kompaniyaning fundamental baholanishi:Grace Therapeutics - GRCE
Grace Therapeutics tayyor mahsulotlari

Sotuv marjalari daromadning har bir dollari ichidagi sof foyda ulushini aks ettiradi va barcha xarajatlar chegirilgandan keyin biznesning umumiy samaradorligini o'lchaydi. Sotuvlarning sof daromadlilik profilini tahlil qilish orqali investor emitentning chidamliligini baholaydi va tizimli o'sishni bir martalik foydalardan ajratadi. Keskin tebranishlar xarajatlar tarkibini qayta ko'rib chiqishni talab qiladi. Grace Therapeutics, Inc. (GRCE) uchun ushbu ko'rsatkich noyob nevrologik patologiyalar terapiyasi sohasidagi eksklyuziv ishlanmalarning monetizatsiyasini tasdiqlaydi. Orfan dori vositalarining yuqori narxi ushbu metrikaning o'sish potentsialini bevosita belgilaydi.

Grace Therapeutics, Inc. (GRCE) raqobatchilari

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Firefly Neuroscience, Inc.|Sof marja ANEW Medical (KLTO)|NRSN - Sof marja|Sotuvning sof marjinal rentabelligi RVPH (Reviva Pharmaceuticals Holdings Inc.)|Kompaniyaning sof rentabelligi MTVA (metaviatx.com)|NeurAxis Inc. - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi heliusmedical.com HSDT|PASG: Sotuvning sof marjinal rentabelligi|Neuphoria - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NERV|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel